Omeprazole and Lymph node tuberculosis - a phase IV clinical study of FDA data
Summary:
Lymph node tuberculosis is reported as a side effect among people who take Omeprazole (omeprazole), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Humira, and have Rheumatoid arthritis.
The phase IV clinical study analyzes which people have Lymph node tuberculosis when taking Omeprazole. It is created by eHealthMe based on reports of 400,982 people who have side effects when taking Omeprazole from the FDA, and is updated regularly.
What is Omeprazole?
Omeprazole has active ingredients of omeprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 410,631 Omeprazole users. Check the latest studies of Omeprazole.
What is Lymph node tuberculosis?
Lymph node tuberculosis is found to be associated with 57 drugs and 173 conditions by eHealthMe. Check the latest studies of Lymph node tuberculosis.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
400,982 people reported to have side effects when taking Omeprazole.
Among them, 21 people (0.01%) have Lymph node tuberculosis.
Among these 21 people:
How long have people been on Omeprazole when they have Lymph node tuberculosis? *
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Lymph node tuberculosis when taking Omeprazole? *
- female: 78.95 %
- male: 21.05 %
What is the age of people who have Lymph node tuberculosis when taking Omeprazole? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 7.69 %
- 30-39: 15.38 %
- 40-49: 15.38 %
- 50-59: 23.08 %
- 60+: 38.46 %
What are other drugs people take besides Omeprazole? *
- Humira: 8 people, 38.10%
- Methotrexate: 7 people, 33.33%
- Folic Acid: 5 people, 23.81%
- Isoniazid: 4 people, 19.05%
- Remicade: 4 people, 19.05%
- Prednisolone: 4 people, 19.05%
- Risedronate Sodium: 3 people, 14.29%
- Calcitriol: 3 people, 14.29%
- Celecoxib: 3 people, 14.29%
- Aspirin: 3 people, 14.29%
What are other side effects people have besides Lymph node tuberculosis? *
- Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 4 people, 19.05%
- Malaise (a feeling of general discomfort or uneasiness): 2 people, 9.52%
- Nausea And Vomiting: 2 people, 9.52%
- Drug Therapeutic Incompatibility: 2 people, 9.52%
- Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 2 people, 9.52%
- Cholestasis (a condition where bile cannot flow from the liver to the duodenum): 2 people, 9.52%
- Nausea (feeling of having an urge to vomit): 2 people, 9.52%
- Necrotising Granulomatous Lymphadenitis (life threatening infection of lymph nodes with collection of immune cells): 2 people, 9.52%
- Alanine Aminotransferase Increased: 2 people, 9.52%
- Pulmonary Tuberculosis (lungs tuberculosis): 2 people, 9.52%
What are the existing conditions these people have? *
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 11 people, 52.38%
- Ankylosing Spondylitis (type of arthritis affecting the spine): 3 people, 14.29%
- Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 9.52%
- Takayasu's Arteritis (an inflammation of the aorta -- the artery that carries blood from the heart to the rest of the body): 1 person, 4.76%
- Pneumocystis Jiroveci Pneumonia (fungal infection of the lungs): 1 person, 4.76%
- Immunodeficiency: 1 person, 4.76%
- Hiv Test Positive: 1 person, 4.76%
- Hiv Infection: 1 person, 4.76%
- Gastric Disorder (disease of stomach): 1 person, 4.76%
* Approximation only. Some reports may have incomplete information.
Do you take Omeprazole and have Lymph node tuberculosis?
- Check whether Lymph node tuberculosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Omeprazole:
- Omeprazole (410,631 reports)
Lymph node tuberculosis treatments and more:
- Lymph node tuberculosis (1,351 reports)
How severe was Lymph node tuberculosis and when was it recovered:
Expand to all the drugs that have ingredients of omeprazole:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Omeprazole:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Lymph node tuberculosis:
- Lymph node tuberculosis (57 drugs)
Browse all the conditions that are associated with Lymph node tuberculosis:
- Lymph node tuberculosis (173 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on omeprazole (the active ingredients of Omeprazole) and Omeprazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
No recent updates.